Completed NA INTERVENTIONAL 2-arm NCT01690312

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Clinical Study to Assess the Acute and Chronic Effects of a High-DHA Fish Oil on Fasting and Post-Prandial Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy.

Sponsor: Biodroga Inc.

Conditions Cardiovascular Disease

Interventions Fish Oil Placebo

Updated 6 times since 2017 Last updated: Feb 6, 2014 Started: Sep 30, 2012 Primary completion: Dec 31, 2013 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cardiovascular Disease, this trial is completed. The trial is conducted by Biodroga Inc. and has accumulated 6 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jan 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biodroga Inc.
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.
University of Guelph

Data source: Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guelph, Canada